China Medical Monitor Industry Report, 2014-2017
  • Dec.2014
  • Hard Copy
  • USD $1,900
  • Pages:71
  • Single User License
    (PDF Unprintable)       
  • USD $1,800
  • Code: ZYM061
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,800
  • Hard Copy + Single User License
  • USD $2,100
      

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market size grew at a CAGR of 21.5%, to RMB4.69 billion in 2013. However, the medical monitor penetration in China was still at a relatively lower level, at 26.5% in 2013, far below the US level of 80%, reflecting great development potential. It is projected that by 2017 the market size of medical monitor industry in China will exceed RMB10 billion.

At present, most medical monitor enterprises in China are still very small and have weak R&D capabilities, and the market is dominated by Mindray, Philips, and GE, which occupy a combined share of roughly 80% in China medical monitor market. Moreover, Philips and GE enjoy absolute superiority in Chinese market of medium and high-end monitors. But under the backdrop of medical reform in China, foreign companies are also expanding their presence in medium and low-end market. For example, GE planned to raise the proportion of medium and high-end monitors and low-end ones in China 50%:50% by 2015.

As a leader in China’s medical monitor industry, Mindray took a 37% market share at home in 2013. Currently, the company is stepping up the expansion in China’s high-end monitor market. Compared with medical imaging system and in-vitro Diagnostics, however, Mindray’s revenue from monitoring products showed a slowdwon in growth rate, with the revenue proportion falling from 44% in 2009 to 36% in the first three quarters of 2014.

Biolight and EDAN Instruments have long been among the second echelon of medical monitor market in China, each with market share of less than 5%. Because of the increasingly intense competition in monitor market and difficulty in surpassing such monitor giants as Mindray, Philips, and GE, the second-echelon enterprises are accelerating the differentiated product layout. And Biolight, hoping to consolidate the medical monitoring product line, continuously improved the hematodialysis layout through M&A, and has completed the layout of the wearable products integrating smartness and mobile health care. In comparison, EDAN Instruments aggressively developed color Doppler ultrasound and POCT businesses, and has successively established 2 related subsidiaries in the United States.

?监护仪 英文_副本.png
Source: China Medical Monitor Industry Report, 2014-2017; ResearchInChina

China Medical Monitor Industry Report, 2014-2017 is primarily concerned with the following:
20120114.gifDevelopment, market size, competitive landscape, import & export, development prediction of medical monitor industry in China;
20120114.gifRegulatory policy, industry policy, access barrier of medical monitors in China and the impact from upstream and downstream sectors, etc.;
20120114.gifOperation and medical monitor business of 4 global and 6 major Chinese monitor manufacturers, etc..

1. Overview of Medical Monitor Industry
1.1 Definition
1.2 Classification

2. Status Quo of Medical Monitor Industry
2.1 Medical Device Market
2.2 Market Size
2.3 Product Segments
2.3.1 Multi-parameter Monitor
2.3.2 Obstetric Monitor
2.4 Imports & Exports
2.4.1 Imports
2.4.2 Exports
2.5 Competitive Landscape
2.6 Profitability
2.7 Entry Barriers
2.7.1 Market Access Barriers
2.7.2 Technical Barriers
2.7.3 Capital Barriers
2.7.4 Talent Barriers
2.8 Technological Level and Trend
2.8.1 Modular Technology
2.8.2 Complete Machine Technology
2.8.3 Informatization Technology

3. Development Environment of Medical Monitors in China
3.1 Policy Environment
3.1.1 Industrial Planning
3.1.2 Regulatory Policy
3.1.3 Import & Export Policy
3.2 Upstream and Downstream Sectors
3.2.1 Upstream Sectors
3.2.2 Downstream Sectors

4. Major Medical Monitor Enterprises
4.1 GE
4.1.1 Profile
4.1.2 Operation
4.1.3 Monitor Business
4.1.4 Development in China
4.2 Philips
4.2.1 Profile
4.2.2 Operation
4.2.3Monitor Business
4.2.4 Development in China
4.3 Nihon Kohden Corp.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4Monitor Business
4.3.5 Business in China
4.4 Fukuda Denshi Co., Ltd.
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Monitor Business
4.4.5 Business in China
4.5 Mindray Medical International Limited
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 R&D and Investment
4.5.6 Medical Monitor Business
4.5.7 Prediction and Outlook
4.6 Guangdong Biolight Meditech Co., Ltd. 
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 R&D and Investment
4.6.6 Medical Monitor Business
4.6.7 Prediction and Outlook
4.7 EDAN Instruments, Inc.
4.7.1 Profile
4.7.2 Operation
6.7.3 Revenue Structure
6.7.4 Gross Margin
6.7.5 R&D
6.7.6 Medical Monitor Business
6.7.7 Prediction and Outlook
4.8 Shenzhen Creative Industry Co., Ltd. 
4.8.1 Profile
4.8.2 Operation
4.9 Beijing Choice Electronic Tech Co., Ltd
4.9.1 Profile
4.9.2 Operation
4.9.3 Development
4.10 Tianrong Medical & Communication Equipment Co.,Ltd 
4.10.1 Profile
4.10.2 Operation
4.10.3 Development

5. Summary and Forecast
5.1 Market Overview
5.2 Enterprise Analysis
Categories of Medical Monitor 
Market Size of Medical Devices in China, 2011-2014  
Number of Diagnostic, Monitoring, and Therapeutic Equipment Manufacturers in China, 2006-2014
Revenue and Profit of Diagnostic, Monitoring, and Therapeutic Equipment Manufacturing in China, 2006-2014  
Market Size of Medical Monitors in China, 2007-2014
Market Structure of Medical Monitors in China by Product, 2013  
Market Size of Multi-parameter Monitors in China, 2007-2014 
Market Size of Obstetric Monitors in China, 2007-2014
Import Volume of Medical Monitors in China, 2007-2014 
Import Value of Medical Monitors in China, 2007-2014
Average Import Price of Medical Monitors in China, 2007-2014 
Import Volume, Import Value, and Unit Import Price for China’s Top 10 Medical Monitor Import Sources by Value, 2013  
Export Volume of Medical Monitors in China, 2007-2014 
Export Value of Medical Monitors in China, 2007-2014 
Average Export Price of Medical Monitors in China, 2007-2014 
Export Volume, Export Value, and Unit Export Price for China’s Top 10 Medical Monitor Export Destinations by Value, 2013  
Proportion of Medical Monitors from Different Chinese Provinces/Municipalities in Total Nationwide by Export Value, 2013
Market Share of Major Medical Monitor Enterprises in China, 2013
Gross Margin of Major Medical Monitor Enterprises in China, 2007-2013  
Planning for Medical Monitor Industry in China, 2006-2013
Number and YoY Growth of Hospitals in China, 2005-2013
Number of Medical Institutions and Hospital Beds in China, 2012-2013
China’s Health Expenditure and % of GDP, 1980-2013 
China’s Health Care Spending Structure, 2005-2013 
Number of Over-65s and % of Total Population in China, 2004-2013 
Per Capita Disposable Income of Urban and Rural Households in China, 2006-2014 
Per Capita Health Care Spending of Urban Chinese and % of Living Expenses, 2006-2012
Per Capita Health Care Spending of Rural Chinese and % of Living Expenses, 2006-2012    
Supportive Policies for Constructing County-level Hospitals, 2009-2014
Revenue and Net Income of GE, 2009-2014 
Revenue Structure of GE Healthcare, 2008-2014  
Revenue and Profit of GE Healthcare, 2008-2014  
Revenue and EBIT of Phillips, 2009-2014 
Phillips Healthcare Business 
Philips Healthcare’s Revenue and % of Total Revenue, 2009-2014  
Revenue Structure of Philips Healthcare by Product, 2010-2013 
Revenue of Philips Healthcare by Region, 2009-2013  
Revenue of Philips in China and YoY Growth, 2011-2014 
Revenue and Net Income of Nihon Kohden Corp., FY2009-FY2014
Gross Margin of Nihon Kohden Corp., FY2009-FY2014
Revenue of Nihon Kohden Corp. by Product, FY2009-FY2014  
Revenue of Nihon Kohden Corp. by Region, FY2009-FY2014  
Monitor Revenue and YoY Growth of Nihon Kohden Corp., FY2009-FY2014  
Revenue and Net Income of Fukuda Denshi, FY2009-FY2014 
Business Segments of Fukuda Denshi 
Revenue of Fukuda Denshi by Product, FY2009-FY2014 
Monitor Revenue and YoY Growth of Fukuda Denshi, FY2009-FY2014 
Fukuda Denshi’s Main Monitor Products in China
Major Subsidiaries of Mindray Medical International as of the End of March 2014 
Revenue and Net Income of Mindray Medical International, 2009-2014  
Revenue of Mindray Medical International by Product, 2009-2014
Revenue Structure of Mindray Medical International by Product, 2009-2013  
Revenue of Mindray Medical International by Region, 2009-2014  
Revenue Structure of Mindray Medical International by Region, 2009-2014   
Gross Margin of Mindray Medical International, 2009-2014  
Mindray Medical International’s R&D Costs and % of Total Revenue, 2009-2014  
Mindray’s Revenue and Gross Margin of Patient Monitoring & Life Support, 2009-2014  
Revenue and Net Income of Mindray Medical International, 2013-2017E
Revenue and Net Income of Biolight, 2009-2014     
Revenue of Biolight by Product, 2009-2014
Revenue of Biolight by Region, 2009-2014 
Gross Margin of Biolight, 2009-2014  
Gross Margin of Biolight by Product, 2009-2014
Biolight’s R&D Costs and % of Total Revenue, 2010-2014  
Monitor Revenue and Gross Margin of Biolight, 2009-2014  
Revenue and Gross Margin of Biolight by Product, 2009-2013
Revenue and Net Income of Biolight, 2013-2017E  
Revenue and Net Income of EDAN Instruments, 2009-2014 
Revenue of EDAN Instruments by Product, 2009-2014
Revenue of EDAN Instruments by Region, 2009-2014  
Gross Margin of EDAN Instruments, 2009-2013  
Gross Margin of EDAN Instruments by Product, 2009-2014  
EDAN Instruments’ R&D Costs and % of Total Revenue, 2011-2014  
Revenue and Gross Margin of Multi-parameter Monitor of EDAN Instruments, 2009-2014
Revenue and Net Income of EDAN Instruments, 2013-2017E
Revenue and Total Profit of Shenzhen Creative, 2007-2009  
Gross Margin of Shenzhen Creative, 2007-2009
Total Assets and Total Liabilities of Shenzhen Creative, 2007-2009
Revenue and Total Profit of Beijing Choice, 2007-2009  
Gross Margin of Beijing Choice, 2007-2009  
Total Assets and Total Liabilities of Beijing Choice, 2007-2009
Revenue and Total Profit of Tianrong Medical, 2007-2009  
Gross Margin of Tianrong Medical, 2007-2009
Total Assets and Total Liabilities of Tianrong Medical, 2007-2009  
Penetration of Medical Monitors in China, 2007-2017E
Market Size of Medical Monitors in China, 2013-2017E  

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号